Vertex Pharmaceuticals Overview
Vertex Pharmaceuticals Target Price
Analysts' 12-month price predictions for VRTX.
Get informed when a big investor buys or sells
+ FollowShare Price
$528.04
Average Target Price
$547.80
3.7% upside
3.7% upside10 analysts in the last 4 months
High: $616 | Low: $436
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-27 | Truist FinancialDanielle Brill | $542 | 2.6% upside |  |
| 2026-05-06 | Barclays | $615 | 16.5% upside | |
| 2026-05-05 | Morgan Stanley | $616 | 16.7% upside | |
| 2026-05-05 | RBC CapitalBrian Abrahams | $543 | 2.8% upside | |
| 2026-05-05 | Bernstein | $572 | 8.3% upside | |
| 2026-05-05 | Canaccord Genuity | $436 |  17.4% downside | |
| 2026-04-30 | Canaccord Genuity | $437 | 17.2% downside | |
| 2026-04-10 | Morgan Stanley | $612 | 15.9% upside | |
| 2026-03-10 | Truist FinancialJoon Lee | $525 | 0.6% downside | |
| 2026-03-10 | JefferiesAkash Tewari | $580 | 9.8% upside | |
| 2026-03-02 | BMO CapitalEvan David Seigerman | $600 | 13.6% upside | |
| 2026-02-17 | Canaccord Genuity | $441 | 16.5% downside | |
| 2026-02-17 | BarclaysEliana Merle | $607 | 15% upside | |
| 2026-02-17 | H.C. WainwrightAndrew Fein | $591 | 11.9% upside | |
| 2026-02-13 | Morgan StanleyTerence Flynn | $570 | 7.9% upside | |
| 2026-02-13 | ScotiabankLouise Chen | $558 | 5.7% upside | |
| 2026-02-13 | RBC Capital | $541 | 2.5% upside | |
| 2026-02-13 | Bernstein | $577 | 9.3% upside | |
| 2026-02-13 | Cantor Fitzgerald | $590 | 11.7% upside | |
| 2026-02-13 | Stifel NicolausPaul Matteis | $466 | 11.7% downside | |
| 2026-02-13 | H.C. WainwrightAndrew Fein | $518 | 1.9% downside | |
| 2026-01-27 | Barclays | $606 | 14.8% upside | |
| 2026-01-26 | UBS | $545 | 3.2% upside | |
| 2026-01-23 | Evercore ISICory Kasimov | $530 | 0.4% upside | |
| 2026-01-22 | RBC CapitalBrian Abrahams | $546 | 3.4% upside | |
| 2026-01-06 | UBSMichael Yee | $535 | 1.3% upside | |
| 2025-12-29 | Leerink Partners | $525 | 0.6% downside | |
| 2025-12-05 | Morgan Stanley | $564 | 6.8% upside | |
| 2025-12-03 | Morgan StanleyTerence Flynn | $516 | 2.3% downside | |
| 2025-11-04 | RBC Capital | $415 | 21.4% downside | |
| 2025-11-04 | Cantor FitzgeraldCarter Gould | $485 | 8.2% downside | |
| 2025-11-04 | Stifel Nicolaus | $445 | 15.7% downside | |
| 2025-11-04 | BarclaysGena Wang | $414 | 21.6% downside | |
| 2025-10-10 | Morgan Stanley | $438 | 17.1% downside | |
| 2025-09-25 | Leerink Partners | $456 | 13.6% downside | |
| 2025-08-05 | Truist Financial | $490 | 7.2% downside | |
| 2025-08-05 | Stifel Nicolaus | $455 | 13.8% downside | |
| 2025-08-05 | UBSEliana Merle | $553 | 4.7% upside | |
| 2025-08-05 | BMO Capital | $530 | 0.4% upside | |
| 2025-08-05 | H.C. Wainwright | $478 | 9.5% downside | |
| 2025-08-05 | Morgan Stanley | $439 | 16.9% downside | |
| 2025-06-17 | RBC CapitalBrian Abrahams | $420 | 20.5% downside | |
| 2025-05-06 | ScotiabankGreg Harrison | $442 | 16.3% downside | |
| 2025-04-22 | Cantor Fitzgerald | $535 | 1.3% upside | |
| 2025-01-31 | BMO CapitalEvan Seigerman | $545 | 3.2% upside | |
| 2025-01-30 | Wells FargoMohit Bansal | $460 | 12.9% downside | |
| 2025-01-10 | Morgan StanleyTerence Flynn | $456 | 13.6% downside | |
| 2024-12-19 | RBC CapitalBrian Abrahams | $400 | 24.2% downside | |
| 2024-12-09 | JefferiesMichael Yee | $550 | 4.2% upside | |
| 2024-11-05 | OppenheimerHartaj Singh | $540 | 2.3% upside | |